Amylyx Pharmaceuticals
AMLX
#5340
Rank
ยฃ1.12 B
Marketcap
ยฃ10.13
Share price
6.83%
Change (1 day)
153.18%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of ยฃ69.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2025

Annual revenue

Year Revenue Change
2025 N/A-100%
2024 ยฃ69.62 M-76.71%
2023 ยฃ0.29 B1526.62%
2022 ยฃ18.37 M
2021 N/A